About Conavi
Conavi is a company based in Toronto (Canada) founded in 2007. Conavi has raised $27.7 million across 5 funding rounds from investors including Titan Medical and FedDev Ontario. Conavi offers products and services including Novasight Hybrid System. Conavi operates in a competitive market with competitors including Infraredx, Acarix, Ionetix, Cleveland HeartLab and GlyCardial Diagnostics, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Conavi Medical Corp.
-
Annual Revenue
$6.55 M (USD)322.12as on Sep 30, 2025
-
Net Profit
-$14.74 M (USD)52.96as on Sep 30, 2025
-
EBITDA
-$9.91 M (USD)46.57as on Sep 30, 2025
-
Total Equity Funding
$27.7 M (USD)
in 5 rounds
-
Latest Funding Round
$700.01 K (USD), Post-IPO
Jan 13, 2026
-
Investors
Titan Medical
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Conavi
Conavi is a publicly listed company on the TSXV with ticker symbol CNVI in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Conavi
Conavi offers a comprehensive portfolio of products and services, including Novasight Hybrid System.
Combines IVUS and OCT for coronary artery imaging and intervention support.
Funding Insights of Conavi
Conavi has successfully raised a total of $27.7M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $700.01 thousand completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Conavi
Conavi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Titan Medical and FedDev Ontario.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Robotic surgical systems for single-access procedures are developed.
|
Locked | Locked | Locked | |
|
It serves as a government backed investment fund focused on the economic growth of southern ontorio.
|
Locked | Locked | Locked |
Investor details for Conavi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Conavi
Investment portfolio details for Conavi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Conavi
Detailed financials for Conavi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Conavi Comparisons
Peer comparison for Conavi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Conavi
Conavi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Infraredx, Acarix, Ionetix, Cleveland HeartLab and GlyCardial Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Coronary imaging and plaque detection system
|
|
| Locked | Locked | Locked |
A screening device for acoustic coronary artery diseases is provided.
|
|
| Locked | Locked | Locked |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| Locked | Locked | Locked |
Cardiovascular biomarkers are utilized for disease prevention and management.
|
|
| Locked | Locked | Locked |
Apo J-Glyc biomarker is commercialized for cardiac ischemia diagnosis.
|
Detailed competitors of Conavi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Conavi
Complete news archive for Conavi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Conavi
Conavi was founded in 2007 and raised its 1st funding round 12 years after it was founded.
Conavi is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Conavi is a funded company, having raised a total of $27.7M across 5 funding rounds to date.
Annual revenue of Conavi is $6.55M as on Sep 30, 2025.
Conavi was founded in 2007 in Toronto, Canada, within the medical devices sector. Operations center on the development of catheter-based ultrasound technology for cardiac applications. The Foresight ICE System has been created, allowing 2D and 3D imaging of cardiac anatomy around the catheter tip. This system supports clinical procedures in cardiology, with focus maintained on imaging precision and integration.
Conavi offers Novasight Hybrid System.
Yes, Conavi is publicly traded on TSXV under the ticker symbol CNVI.
Conavi has 2 investors. Key investors include Titan Medical, and FedDev Ontario.
The ticker symbol of Conavi is CNVI on TSXV.